GetTopicDetailResponse(id=e8856108ca, topicName=DNA損傷響應(yīng)抑制劑, introduction=DNA損傷響應(yīng)抑制劑, content=null, image=null, comments=1, allHits=690, url=https://h5.medsci.cn/topic?id=6108, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=96333, tagList=[TagDto(tagId=96333, tagName=DNA損傷響應(yīng)抑制劑)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1784642, encodeId=a1c01e84642d2, content=<a href='/topic/show?id=e8856108ca' target=_blank style='color:#2F92EE;'>#DNA損傷響應(yīng)抑制劑#</a>, objectTitle=Onxeo喜獲美國(guó)專利，允許將DNA損傷響應(yīng)抑制劑AsiDNA與所有PARP抑制劑聯(lián)合用于癌癥治療, objectType=article, longId=182458, objectId=fe5d1824588f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe5d1824588f, replyNumber=0, likeNumber=101, createdTime=2020-07-06, rootId=0, userName=bbwuyu_003, userId=60b4474, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe5d1824588f, moduleTitle=Onxeo喜獲美國(guó)專利，允許將DNA損傷響應(yīng)抑制劑AsiDNA與所有PARP抑制劑聯(lián)合用于癌癥治療, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=fe5d1824588f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
